Please provide your email address to receive an email when new articles are posted on . Cataract surgery is a refractive procedure, and modern advances in that field have resulted in higher ...
Please provide your email address to receive an email when new articles are posted on . With advancing technology, cataract surgery is now less invasive, resulting in better recovery and outcomes. Not ...
Pellucid marginal degeneration (PMD) is an idiopathic, noninflammatory thinning disorder normally involving the inferior peripheral part of the cornea, concentric with the limbus, between the 4 and 8 ...
With refractive outcomes for cataract surgery becoming increasingly precise, expectations for astigmatism correction are rising in equal measure. Although toric intraocular lens (IOL) implants have ...
Vision techniques have become so sophisticated that you can sit in a chair, feel absolutely nothing, and walk out 30 minutes later with 20/20 vision. And, not only that, the knowledge imparted by an ...
Aging is a natural part of life, and as we grow older, our bodies go through various changes. Our hair turns gray, our joints ache a bit more and our energy levels fluctuate. But one aspect of aging ...
The US Food and Drug Administration (FDA) has just approved Abbott's Tecnis Toric 1-piece intraocular lens (IOL) to treat preexisting astigmatism in patients with cataract. The blurry vision of ...
First Preloaded Toric Available in the United States and Monofocal Option Combine Consistent IOL Delivery with Outstanding Visual Outcomes of enVista® LAVAL, QC, Oct. 27, 2020 /PRNewswire/ -- Bausch + ...
ABBOTT PARK, Ill., April 18, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the TECNIS ® Toric 1-Piece intraocular lens (IOL) has received U.S. Food and Drug Administration (FDA) ...
PanOptix delivers an exceptional combination of near, intermediate and distance vision and substantially reduces the need for glasses 1,2 More than ninety-nine percent of PanOptix patients in the FDA ...
VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the ...